Financial Performance - Neuraxis, Inc. announced preliminary unaudited estimated revenues for Q4 2024 and the full year ended December 31, 2024[4]. - The financial information provided is preliminary and subject to changes following the completion of the company's normal financial close procedures[5]. - The preliminary financial information does not include all necessary details for a complete understanding of the company's financial condition[5]. Audit and Compliance - The company’s financial statements for the year ended December 31, 2024, are currently undergoing an audit[5]. - The filing does not incorporate the information into any registration statements under the Securities Act[6]. Company Information - Neuraxis, Inc. is classified as an emerging growth company under the Securities Act[3]. - The company is listed on the NYSE American under the trading symbol NRXS[2]. - The report was signed by Brian Carrico, President and CEO of Neuraxis, Inc.[11]. Press Release - The press release regarding the preliminary results was issued on January 8, 2025[4]. - The press release is included as Exhibit 99.1 in the filing[8].
Neuraxis(NRXS) - 2024 Q4 - Annual Results